Clinical Trials Sponsored by Cantex Pharmaceuticals
Total 88137 results
-
Center Trials & TreatmentBioGene PharmaceuticalWithdrawnBreast Neoplasm | Advanced or Recurrent Solid TumorsAlbania
-
Santen Pharmaceutical(China) Co.,LTDCompletedDry Eye Syndromes | Sjögren SyndromeChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Taiho Pharmaceutical Co., Ltd.CompletedLiver CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Otsuka America PharmaceuticalCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Novartis PharmaceuticalsVanda PharmaceuticalsCompletedSchizophreniaUnited States
-
Endo PharmaceuticalsTeva Pharmaceuticals USACompletedStutteringUnited States
-
Nucorion Pharmaceuticals, Inc.Ligand PharmaceuticalsCompletedChronic Hepatitis BUnited States
-
Semafore PharmaceuticalsSignalRX Pharmaceuticals, Inc.CompletedCancer | Advanced or Metastatic Solid Tumors | Solid CancersUnited States
-
Conatus Pharmaceuticals Inc.Idun PharmaceuticalsCompleted
-
Conatus Pharmaceuticals Inc.Idun PharmaceuticalsCompletedLiver Transplantation | Hepatitis | Carcinoma, Hepatocellular | CholestasisUnited States, Germany
-
Erasmus Medical CenterISA Pharmaceuticals B.V.RecruitingChronic Hepatitis bNetherlands
-
University Medical Center GroningenRegeneron PharmaceuticalsActive, not recruiting
-
Boston Medical CenterSpectrum Pharmaceuticals, IncTerminatedAmyloidosis; SystemicUnited States
-
Roswell Park Cancer InstituteTetraLogic PharmaceuticalsTerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedHypopharyngeal Cancer | HPV Positive Oropharyngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Early Invasive Cervical Squamous Cell Carcinoma | Cancer of Nasopharynx | Carcinoma of LarynxUnited States
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
Genuine Research Center, EgyptMinaPharm PharmaceuticalsCompleted
-
Montefiore Medical CenterAmylin Pharmaceuticals, LLC.CompletedType 1 Diabetes MellitusUnited States
-
Tufts Medical CenterSpectrum Pharmaceuticals, IncTerminatedMultiple MyelomaUnited States
-
Vanderbilt University Medical CenterNeilMed PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)Completed
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)Completed
-
Regeneron PharmaceuticalsNational Cancer Institute (NCI)CompletedLymphoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Maxim PharmaceuticalsNational Cancer Institute (NCI)UnknownMetastatic Cancer | Melanoma (Skin)United States, Canada, Germany, United Kingdom
-
LifeTime PharmaceuticalsUnknown
-
Vion PharmaceuticalsCompleted
-
Vion PharmaceuticalsCompletedLeukemiaFrance, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
-
Vion PharmaceuticalsCompletedPancreatic CancerUnited States, United Kingdom, Belgium
-
Aventis PharmaceuticalsCompleted
-
MetroHealth Medical CenterTeva Pharmaceuticals USACompletedObstructive Sleep ApneaUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Vion PharmaceuticalsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Daiichi PharmaceuticalsCompletedLung CancerGermany, United Kingdom, Finland, Italy, Netherlands
-
Ligand PharmaceuticalsCompletedLymphoma | Drug/Agent Toxicity by Tissue/OrganUnited States
-
BioCryst PharmaceuticalsCompleted
-
OHSU Knight Cancer InstituteAriad PharmaceuticalsNo longer availableChronic Myeloid Leukemia | Philadelphia Chromosome Positive (Ph+) LeukemiasUnited States
-
British Columbia Cancer AgencyFerring PharmaceuticalsUnknown
-
University Medical Center GroningenNovartis PharmaceuticalsCompletedNeuroendocrine TumorsNetherlands
-
Red Rock Fertility CenterWatson PharmaceuticalsUnknownInfertility, FemaleUnited States
-
Leiden University Medical CenterNovartis PharmaceuticalsUnknownUveal Melanoma
-
Peregrine PharmaceuticalsCompletedBrain and Central Nervous System TumorsUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedNeoplasms | LymphomaUnited Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Rush University Medical CenterNovartis PharmaceuticalsRecruitingHypertensionUnited States
-
Vanderbilt University Medical CenterVeloxis PharmaceuticalsRecruitingRenal TransplantUnited States
-
Lindner Center of HOPEJazz PharmaceuticalsRecruiting
-
Cumberland PharmaceuticalsVanderbilt University Medical CenterRecruitingCardiomyopathy, Dilated | Duchenne Muscular Dystrophy CardiomyopathyUnited States